Bayer

Acarbose is an oral alpha-glucosidase inhibitor for type 2 diabetes. It slows the enzymes that digest starch and sucrose in the small intestine, so glucose enters the blood more gradually and post-meal blood sugar rises stay smaller. It is used alongside diet and exercise in adults.

When you eat carbohydrates, enzymes in the small intestine cut them into glucose, which then passes into the blood. Acarbose reversibly blocks those e

Eylea (aflibercept) is a VEGF inhibitor from Bayer that acts as a decoy receptor, trapping vascular endothelial growth factor before it can stimulate abnormal blood vessel growth in the retina. It is injected into the eye to treat neovascular age-related macular degeneration, diabetic macular oedema, macular oedema after retinal vein occlusion, diabetic retinopathy, and retinopathy of prematurity.

Aflibercept is an engineered protein that circulates in the eye after an injection. It binds to vascular endothelial growth factor (VEGF-A), VEGF-B, a

Aspirin (acetylsalicylic acid) is a salicylate that relieves pain and fever and, by dampening platelet clumping, helps prevent heart attacks and strokes. It is one of the oldest medicines still in wide use, both for everyday aches and for cardiovascular protection.

Pain, fever and inflammation are driven by hormone-like chemicals called prostaglandins, made by enzymes named cyclooxygenases. Aspirin permanently di

Nubeqa (darolutamide) is an androgen receptor inhibitor from Bayer for prostate cancer. It blocks the receptor that drives tumour growth and is used in non-metastatic castration-resistant disease and, with androgen deprivation therapy, in metastatic hormone-sensitive disease.

Most prostate cancers depend on androgen hormones acting through the androgen receptor. Treatments that lower hormone levels help, but the receptor ca

Xarelto (rivaroxaban) is an oral factor Xa inhibitor from Bayer that blocks a key enzyme of the clotting cascade. It prevents and treats deep vein thrombosis and pulmonary embolism, reduces stroke risk in atrial fibrillation, and lowers cardiovascular events after acute coronary syndromes or in coronary and peripheral artery disease.

Rivaroxaban is taken by mouth and belongs to the factor Xa inhibitor class. It selectively blocks factor Xa, an enzyme the body needs to turn prothrom